NOS2 and pulmonary emphysema: Hence, understanding the exact mechanism by which iNOS inhibition in emphysematous lungs elicits their regeneration and repair and identification of the responsible cell type is an important step toward the transfer of an iNOS inhibition strategy to a clinical trial and potential treatment of emphysema in humans.